These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2941373)

  • 21. Decreased sensitivity of spontaneously hypertensive rat aortic smooth muscle to vasorelaxation by atriopeptin III.
    Sauro MD; Fitzpatrick DF
    Biochem Biophys Res Commun; 1987 Jul; 146(1):80-6. PubMed ID: 2955788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of nialamide on responses of dog isolated arteries to tyramine and transmural electrical stimulation.
    Hayashi S; Park MK
    Gen Pharmacol; 1984; 15(1):19-24. PubMed ID: 6421649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic atrial natriuretic factor is a specific dilator of noradrenaline and serotonin activated renal resistance vessels.
    Mulvany MJ; Aalkjaer C; Juul B; Nyborg NC; Andresen J
    J Hypertens Suppl; 1985 Dec; 3(3):S307-9. PubMed ID: 2856724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of prostaglandins and arachidonic acid on baboon cerebral and mesenteric arteries.
    Hayashi S; Park MK; Kuehl TJ
    Prostaglandins; 1986 Oct; 32(4):587-96. PubMed ID: 3099335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of atrial natriuretic peptide on coronary vascular resistance in the intact awake dog.
    Laxson DD; Dai XZ; Schwartz JS; Bache RJ
    J Am Coll Cardiol; 1988 Mar; 11(3):624-9. PubMed ID: 2963852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional differences in the regulation of contraction-relaxation machinery of vascular smooth muscle.
    Kovach AG; Dora E; Farago M; Horvath IH; Szabo C
    Adv Exp Med Biol; 1989; 248():601-9. PubMed ID: 2782178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diminished mesenteric vaso- and venoconstriction and elevated plasma ANP and BNP with simulated microgravity.
    Behnke BJ; Zawieja DC; Gashev AA; Ray CA; Delp MD
    J Appl Physiol (1985); 2008 May; 104(5):1273-80. PubMed ID: 18218919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of atriopeptin II to cause arterial vasodilation in the conscious rat.
    Lappe RW; Smits JF; Todt JA; Debets JJ; Wendt RL
    Circ Res; 1985 Apr; 56(4):606-12. PubMed ID: 3156690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the natriuretic effect of atrial natriuretic factor in conscious rats mediated by renal vasodilatation?
    Sonnenburg C; Muir AC; Criscione L; Kraetz J; Hofbauer KG
    J Hypertens Suppl; 1985 Dec; 3(3):S303-5. PubMed ID: 2856723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sympathectomy fails to reveal prominent vasodilation by atrial natriuretic factor.
    Barbee RW; Harrison-Bernard LM; Zimmerman RS; Trippodo NC; Frohlich ED
    Hypertension; 1990 Jun; 15(6 Pt 2):888-93. PubMed ID: 2141004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium sensitivity and agonist-induced calcium sensitization in small arteries of young and adult spontaneously hypertensive rats.
    Shaw LM; Ohanian J; Heagerty AM
    Hypertension; 1997 Sep; 30(3 Pt 1):442-8. PubMed ID: 9314430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats.
    Gradin KA; Li JY; Andersson O; Simonsen U
    J Vasc Res; 2003; 40(3):252-65. PubMed ID: 12902638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trimethaphan is a direct arterial vasodilator and an alpha-adrenoceptor antagonist.
    Harioka T; Hatano Y; Mori K; Toda N
    Anesth Analg; 1984 Mar; 63(3):290-6. PubMed ID: 6142667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responsiveness to vasoactive agents of cerebral and mesenteric arteries isolated from control and reserpine-treated dogs.
    Hayashi S; Miyazaki M; Toda N
    Br J Pharmacol; 1980 Mar; 68(3):473-8. PubMed ID: 7052340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of synthetic atrial natriuretic factor: vasodilator profile and decreased vascular sensitivity in hypertensive rats.
    Winquist RJ; Faison EP; Baskin EP; Bunting PB; Nutt RF; Callahan LT
    J Hypertens Suppl; 1984 Dec; 2(3):S325-7. PubMed ID: 6242561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathological role of a constitutively active population of alpha(1D)-adrenoceptors in arteries of spontaneously hypertensive rats.
    Gisbert R; Ziani K; Miquel R; Noguera MA; Ivorra MD; Anselmi E; D'Ocon P
    Br J Pharmacol; 2002 Jan; 135(1):206-16. PubMed ID: 11786496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of atriopeptin III on isolated rat afferent and efferent arterioles.
    Lanese DM; Yuan BH; Falk SA; Conger JD
    Am J Physiol; 1991 Dec; 261(6 Pt 2):F1102-9. PubMed ID: 1661082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial natriuretic factor causes specific relaxation of rat renal arcuate arteries.
    Aalkjaer C; Mulvany MJ; Nyborg NC
    Br J Pharmacol; 1985 Oct; 86(2):447-53. PubMed ID: 2932194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute and chronic effects of relaxin on vasoactivity, myogenic reactivity and compliance of the rat mesenteric arterial and venous vasculature.
    Li Y; Brookes ZL; Kaufman S
    Regul Pept; 2005 Dec; 132(1-3):41-6. PubMed ID: 16229906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
    Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
    Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.